Sarcoma: open trials in China

• NCT06836505

  Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.

  Trial Treatment · Phase 1/2 · Sun Yat-Sen University Cancer Center

  Dongguan Taixin Hospital, Dongguan · Sun Yat-sen University Cancer Center, Guangzhou · Shanghai YaKe Biotechnology Ltd., Shanghai

  Registry updated 2025-02-26

• NCT06836492

  A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.

  Trial Treatment · Phase 3 · Yizhuo Zhang

  Suying Lu, Guangzhou

  Registry updated 2025-02-20

• NCT06816771

  Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents

  Trial Treatment · Phase 2 · Shandong Cancer Hospital and Institute

  No. 440 Jiyan Road, Jinan City, Shandong Province, Jinan

  Registry updated 2025-02-10

• NCT06778603

  B7-H3 NIR Imaging for Osteosarcoma Surgery

  Trial Treatment · Phase 1/2 · Peking University People's Hospital

  Musculoskeletal Tumor Center, Beijing

  Registry updated 2025-01-16

• NCT06760221

  Safety and Efficacy of Preoperative SBRT and Radical Surgery for Soft Tissue Sarcoma of Extremities

  Trial Treatment · Second Affiliated Hospital, Zhejiang University, School of Medicine

  the second affiliated hospital of Zhejiang University Hangzhou, Zhejiang, China, 310009, Hangzhou

  Registry updated 2025-01-06

• NCT06126510

  Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma

  Trial Treatment · Phase 2 · CNBG-Virogin Biotech (Shanghai) Ltd.

  Peking University People's Hospital, Beijing

  Registry updated 2024-12-24

• NCT06684327

  Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors

  Trial Treatment · Phase 2 · Fudan University

  Fudan University Cancer hospital, Shanghai

  Registry updated 2024-12-20

• NCT06644287

  The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Soft Tissue Sarcomas

  Research · Ruijin Hospital

  Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine, Shanghai

  Registry updated 2024-12-13

• NCT06714383

  Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma

  Trial Treatment · Phase 2 · Peking University People's Hospital

  Peking University People's Hospital, Beijing

  Registry updated 2024-12-03

• NCT06699472

  A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib

  Trial Treatment · Phase 2 · Fudan University

  Fudan University Shanghai Cencer Center,, Shanghai

  Registry updated 2024-11-21

• NCT06694324

  First-line Treatment of Advanced/unresectable DDLPS

  Trial Treatment · Phase 2 · Fudan University

  Fudan University Cancer hospital, Shanghai

  Registry updated 2024-11-19

• NCT05830123

  ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas

  Trial Treatment · Phase 2 · Hansoh BioMedical R&D Company

  Peking University People's Hospital, Beijing · Hunan Cancer Hospital, Changsha · Sun Yat-sen University Cancer Center, Guangzhou · First Affiliated Hospital, Sun Yat-Sen University, Guangzhou · Zhejiang Cancer Hospital, Hangzhou · Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou · Chinese PLA General Hospital of Eastern Theater Command, Nanjing · Shanghai General Hospital, Shanghai · Shanghai 6th People's Hospital, Shanghai · Tianjin Cancer Hospital, Tianjin · Henan Cancer Hospital, Zhengzhou

  Registry updated 2024-08-23

• NCT06564272

  A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma

  Trial Treatment · Phase 2 · Beijing Konruns Pharmaceutical Co., Ltd.

  Beijing Children's Hospital Affiliated to Capital Medical University, Beijing

  Registry updated 2024-08-23

• NCT06550765

  Safety and Efficacy of Degradable Magnesium Metal Clips in Surgical Margins of Radical Surgery for Malignant Bone and Soft Tissue Tumors

  Trial Treatment · Guangdong Provincial People's Hospital

  Guangdong Provincial People's Hospital, Guangzhou

  Registry updated 2024-08-13

• NCT06506838

  Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma

  Trial Treatment · Phase 4 · Guangdong Provincial People's Hospital

  Guangdong Provincial People's Hospital, Guangzhou

  Registry updated 2024-08-12

• NCT06514313

  Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma.

  Trial Treatment · Phase 2 · Yizhuo Zhang

  Sun Yat-sen University Cancer Center, Guangzhou

  Registry updated 2024-07-23

• NCT06111612

  Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement

  Research · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

  Shanghai General Hospital, Shanghai

  Registry updated 2024-07-22

• NCT06500091

  TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors

  Trial Treatment · Phase 2 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

  Beijing Cancer Hospital, Beijing · Cancer Hospital Chinese Academy of Medical Science, Beijing · Jilin Cancer Hospital, Changchun · Hunan Cancer Hospital, Changsha · Zhe Jiang Cancer Hospital, Hangzhou · Cancer Hospital Affiliated to Shandong First Medical University, Jinan · Fudan University Shanghai Cancer Center, Shanghai · Shanxi Cancer hospital, Taiyuan · Tianjin Medical University Cancer Institute and Hospital, Tianjin · Xinjiang Medical University Affiliated Cancer Hospital, Ürümqi · Henan Cancer Hospital,Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou

  Registry updated 2024-07-15

• NCT05187338

  Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors

  Trial Treatment · Phase 1/2 · Second Affiliated Hospital of Guangzhou Medical University

  The second Affiliated Hospital of Guangzhou Medical University, Guangzhou

  Registry updated 2024-06-25

• NCT06456892

  Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen

  Trial Treatment · Phase 1/2 · Sun Yat-sen University

  Sun Yat-sen University Cancer Center, Guangzhou

  Registry updated 2024-06-13

• NCT06340204

  Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma

  Trial Treatment · Phase 1 · Peking University People's Hospital

  Peking University People's Hospital, Beijin · Peking University Shougang Hospital, Beijing · Shandong Cancer Hospital and Institute, Jina

  Registry updated 2024-04-03

• NCT06236022

  The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus

  Trial Treatment · Phase 4 · Tongji Hospital

  Tongji Hospital, Wuhan

  Registry updated 2024-02-01

• NCT06114225

  Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial

  Trial Treatment · Phase 2 · Ruijin Hospital

  Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

  Registry updated 2023-11-02

• NCT06074692

  PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)

  Trial Treatment · Phase 2 · Ruijin Hospital

  Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

  Registry updated 2023-10-31

• NCT06062927

  Geno-radiomics Based Model for Evaluation of Immunotherapy and Targeted Therapy for Advanced Soft Tissue Sarcoma

  Research · Peking Union Medical College Hospital

  Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

  Registry updated 2023-10-02

All Sarcoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error